TCTR20190422001招募中未知
Immune response after diphtheria and tetanus toxoid booster in patients with adult onset immunodeficiency with anti-interferon gamma autoantibody
Ratchadapiseksompoch funds0 个研究点目标入组 36 人开始时间: 2019年4月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- All
入选标准
- •Age > 18 years who diagnosed with interferon gamma autoantibody
排除标准
- •HIV positive
研究者
相似试验
已完成
2 期
A phase II/III randomized, observer-blind, active-controlled study to compare non-inferior immunogenicity of a combined Diphtheria-Tetanus-recombinant acellular pertussis (DTaP) vaccine to a licensed DTaP based vaccine (non-recombinant), when administered to healthy toddlers aged of 15-36 months oldPertussisTCTR20200325002Vaccine Trial Centre (VTC), Faculty of Tropical Medicine, Mahidol Uiversity290
进行中（未招募）
不适用
Immunogenicity and safety of a tetanus, diphtheria and mono component acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as a booster vaccination to adultsThe intended use of the vaccine in this study is to increase the immunological protection against pertussis in adults who completed primary vaccination with diphtheria, tetanus and pertussis vaccine typically during their childhood.MedDRA version: 12.0Level: LLTClassification code 10034738Term: PertussisEUCTR2009-013411-36-DKStatens Serum Institut
进行中（未招募）
不适用
Safety and Immunogenicity of ADACEL™ (TdcP Vaccine) Compared with QUADRACEL™ (HCPDT-mIPV Vaccine) as Fifth Dose in Children 4-6 Years of AgeEUCTR2015-005589-43-Outside-EU/EEASanofi Pasteur Limited600
已完成
不适用
Evaluation of the immune system response to Diphtheria and Tetanus vaccination in HIV positive patientsHIV AIDS.Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseasesIRCT201211204076N8Resaerch Deputy tehran university of medical sciences300
已完成
2 期
Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated PoliomyelitisPoliomyelitisHepatitis BDiphtheriaTetanusPertussisNCT02040636Sanofi Pasteur, a Sanofi Company277